SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.890-6.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
alwaysbmiki
To: Straynut who wrote (12757)5/18/2020 7:45:57 AM
From: old 'n cranky1 Recommendation  Read Replies (1) of 12871
 
Is there room on the board for one more? Honorable Mr. Todd Rokita, J.D., former member of the U.S. House of Representatives from Indiana's driver may need to keep him company:
nypost.com

But this might be a more relevant concern:
indems.org

He's also considering vying for a position that might compete for his time:
"Former U.S. Rep. Todd Rokita, R-Brownsburg, issued a statement Monday declaring his interest in the office and promising to decide before next week's filing deadline whether to compete for the attorney general nomination at the June 20 Republican state convention."
kokomoperspective.com

Dr. Makarand Jawadekar, the most recent independent director to NNVC's Board, and "long term good friend", recommended Mr. Rokita for the job.

Dr. J already has an interesting side job. He's President and Chief Scientific Officer of PreveCeutical. PreveCeutical Medical Inc. (CSE: PREV) is a health and wellness company, focused on developing natural and nature identical products for the benefit of health-conscious consumers. Headquartered in Vancouver, last year PreveCeutical finished up with a Cash balance of $28,480 on Revenues of $3,031, losing $3,578,900 in the process (Canadian dollars). The product they list at the top of their pipeline is described as involving "Nose-to-Brain Delivery of Therapeutic Cannabinoids".
"Mak" says "we would welcome an opportunity to work with a pharmaceutical or biotechnology company to co-develop the Sol-Gel and sol-gel Applicator to be used in pharmaceutical and therapeutic products."

A nasal Cannabinoid vape....an idea looking for a partner. He'll fit right in here.

Continued good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext